Overview

Study Evaluating Oral MOA-728 in Subjects on Methadone Therapy

Status:
Withdrawn
Trial end date:
2007-12-01
Target enrollment:
Participant gender:
Summary
To evaluate the effects of single oral doses of MOA-728 compared to a positive control in subjects on methadone therapy.
Phase:
Phase 1
Details
Lead Sponsor:
Bausch Health Americas, Inc.
Valeant Pharmaceuticals International, Inc.
Treatments:
Methadone